-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Medical Network News on June 3 At present, provinces have successively released provincial-level centralized procurement plans for 2021.
On June 1, the Anhui Provincial Medical Insurance Bureau issued the "2021 Anhui Province Drug Centralized Procurement Work Plan", which will select large-volume, high-value, and relatively competitive drugs from unreviewed drugs, and carry out provincial-level centralized procurement.
Use bidding, bargaining, etc.
to determine the selected enterprises .
Use bidding, bargaining, etc.
to determine the selected enterprises .
Implementation scope: Public medical institutions and military medical institutions in the whole province should participate.
Medical insurance designated social medical institutions shall be implemented in accordance with the requirements of designated agreement management.
Medical insurance designated social medical institutions shall be implemented in accordance with the requirements of designated agreement management.
Procurement cycle: In principle, the procurement cycle of selected drugs is not less than one year.
If the selected varieties are included in the scope of centralized drug procurement organized by the state, or if the procurement cycle needs to be adjusted for other reasons, follow-up related announcements shall prevail.
If the selected varieties are included in the scope of centralized drug procurement organized by the state, or if the procurement cycle needs to be adjusted for other reasons, follow-up related announcements shall prevail.
Drug Scope: Among the generic drugs corresponding to generic drugs that have never passed the consistency evaluation, select some drugs with large clinical usage, high purchase amount, and relatively sufficient competition, and organize the province's large-scale procurement.
Finalist standards: including quality finalist standards and supply finalist standards.
The quality entry standards mainly consider the clinical efficacy of drugs, the safety of use, supervision and sampling, and quality standards.
The supply shortlisted criteria mainly consider the production capacity and supply stability of the enterprise.
The quality entry standards mainly consider the clinical efficacy of drugs, the safety of use, supervision and sampling, and quality standards.
The supply shortlisted criteria mainly consider the production capacity and supply stability of the enterprise.
Procurement form: Determine the review group according to the attributes, quality and market structure of the purchased drugs, comprehensively consider the quality, efficacy, adverse reactions and prices of the drugs and other factors, and determine the selected companies in the form of bidding and bargaining according to the competitive situation.
With the amount of purchases to the amount of the price change.
Calculate the agreed total purchase amount of the selected drugs based on not less than 50% of the total consumption of relevant drugs in the alliance medical institutions last year, carry out the purchase with a quantity, and implement the agreed purchase volume of the selected drugs to each medical institution in the alliance.
Calculate the agreed total purchase amount of the selected drugs based on not less than 50% of the total consumption of relevant drugs in the alliance medical institutions last year, carry out the purchase with a quantity, and implement the agreed purchase volume of the selected drugs to each medical institution in the alliance.
Combination of recruitment and acquisition, guaranteed use.
For the selected varieties, the alliance medical institutions shall give priority to use, to ensure that the agreed procurement volume is completed within the procurement cycle.
For the remaining amount, medical institutions can purchase other online varieties at a reasonable price through the provincial platform under the premise of giving priority to purchasing and ensuring the completion of the selected drugs.
Public medical institutions implement "zero markup sales" according to the selected price, and second bargaining is strictly prohibited.
For the selected varieties, the alliance medical institutions shall give priority to use, to ensure that the agreed procurement volume is completed within the procurement cycle.
For the remaining amount, medical institutions can purchase other online varieties at a reasonable price through the provincial platform under the premise of giving priority to purchasing and ensuring the completion of the selected drugs.
Public medical institutions implement "zero markup sales" according to the selected price, and second bargaining is strictly prohibited.
The fund is paid in advance and the funds are paid back in time.
On the basis of the total budget of the medical insurance fund, the medical insurance agencies in the overall planning area shall prepay to medical institutions no less than 30% of the agreed annual purchase amount as a working capital for the medical institutions to pay the enterprise for drug purchases, and the special funds are used for special purposes.
On the basis of the total budget of the medical insurance fund, the medical insurance agencies in the overall planning area shall prepay to medical institutions no less than 30% of the agreed annual purchase amount as a working capital for the medical institutions to pay the enterprise for drug purchases, and the special funds are used for special purposes.
Improve the coordination mechanism of drug procurement and medical insurance fund management
The plan pointed out that for medical institutions that reduce their medical insurance fund expenditures due to standardized use of selected drugs, the total budget of the medical insurance fund for the current year will not be reduced.
In principle, to carry out by a single disease, according to the diagnosis of diseases related group, according to scores by paying a fixed bed and Japan, do not purchase because with the amount of drug costs decline and reduce its fixed payments standard .
Designated medical institutions that give priority to the use of selected drugs and fulfill their contracts as required shall be encouraged in accordance with the relevant policies for the retention of the balance of the medical insurance fund for centralized procurement of drugs.
Establish a coordination mechanism for procurement prices and medical insurance payment standards, and specific supporting policies will be formulated separately.
Establish a coordination mechanism for procurement prices and medical insurance payment standards, and specific supporting policies will be formulated separately.
Simplify the procurement procedures, give priority to the procurement and use of selected drugs, and ensure the completion of the contract dosage.
Medical institutions that do not purchase and use selected drugs in accordance with regulations will be punished in the total amount of medical insurance indicators, medical insurance designated qualifications, medical institution performance evaluation, and medical institution responsible persons’ target responsibility evaluation.
Medical institutions that do not purchase and use selected drugs in accordance with regulations will be punished in the total amount of medical insurance indicators, medical insurance designated qualifications, medical institution performance evaluation, and medical institution responsible persons’ target responsibility evaluation.
Medical Network News on June 3 At present, provinces have successively released provincial-level centralized procurement plans for 2021.
On June 1, the Anhui Provincial Medical Insurance Bureau issued the "2021 Anhui Province Drug Centralized Procurement Work Plan", which will select large-volume, high-value, and relatively competitive drugs from unreviewed drugs, and carry out provincial-level centralized procurement.
Use bidding, bargaining, etc.
to determine the selected enterprises .
Use bidding, bargaining, etc.
to determine the selected enterprises .
Implementation scope: Public medical institutions and military medical institutions in the whole province should participate.
Medical insurance designated social medical institutions shall be implemented in accordance with the requirements of designated agreement management.
Medical insurance designated social medical institutions shall be implemented in accordance with the requirements of designated agreement management.
Procurement cycle: In principle, the procurement cycle of selected drugs is not less than one year.
If the selected varieties are included in the scope of centralized drug procurement organized by the state, or if the procurement cycle needs to be adjusted for other reasons, follow-up related announcements shall prevail.
If the selected varieties are included in the scope of centralized drug procurement organized by the state, or if the procurement cycle needs to be adjusted for other reasons, follow-up related announcements shall prevail.
Drug Scope: Among the generic drugs corresponding to generic drugs that have never passed the consistency evaluation, select some drugs with large clinical usage, high purchase amount, and relatively sufficient competition, and organize the province's large-scale procurement.
Finalist standards: including quality finalist standards and supply finalist standards.
The quality entry standards mainly consider the clinical efficacy of drugs, the safety of use, supervision and sampling, and quality standards.
The supply shortlisted criteria mainly consider the production capacity and supply stability of the enterprise.
The quality entry standards mainly consider the clinical efficacy of drugs, the safety of use, supervision and sampling, and quality standards.
The supply shortlisted criteria mainly consider the production capacity and supply stability of the enterprise.
Procurement form: Determine the review group according to the attributes, quality and market structure of the purchased drugs, comprehensively consider the quality, efficacy, adverse reactions and prices of the drugs and other factors, and determine the selected companies in the form of bidding and bargaining according to the competitive situation.
With the amount of purchases to the amount of the price change.
Calculate the agreed total purchase amount of the selected drugs based on not less than 50% of the total consumption of relevant drugs in the alliance medical institutions last year, carry out the purchase with a quantity, and implement the agreed purchase volume of the selected drugs to each medical institution in the alliance.
Calculate the agreed total purchase amount of the selected drugs based on not less than 50% of the total consumption of relevant drugs in the alliance medical institutions last year, carry out the purchase with a quantity, and implement the agreed purchase volume of the selected drugs to each medical institution in the alliance.
Combination of recruitment and acquisition, guaranteed use.
For the selected varieties, the alliance medical institutions shall give priority to use, to ensure that the agreed procurement volume is completed within the procurement cycle.
For the remaining amount, medical institutions can purchase other online varieties at a reasonable price through the provincial platform under the premise of giving priority to purchasing and ensuring the completion of the selected drugs.
Public medical institutions implement "zero markup sales" according to the selected price, and second bargaining is strictly prohibited.
For the selected varieties, the alliance medical institutions shall give priority to use, to ensure that the agreed procurement volume is completed within the procurement cycle.
For the remaining amount, medical institutions can purchase other online varieties at a reasonable price through the provincial platform under the premise of giving priority to purchasing and ensuring the completion of the selected drugs.
Public medical institutions implement "zero markup sales" according to the selected price, and second bargaining is strictly prohibited.
The fund is paid in advance and the funds are paid back in time.
On the basis of the total budget of the medical insurance fund, the medical insurance agencies in the overall planning area shall prepay to medical institutions no less than 30% of the agreed annual purchase amount as a working capital for the medical institutions to pay the enterprise for drug purchases, and the special funds are used for special purposes.
On the basis of the total budget of the medical insurance fund, the medical insurance agencies in the overall planning area shall prepay to medical institutions no less than 30% of the agreed annual purchase amount as a working capital for the medical institutions to pay the enterprise for drug purchases, and the special funds are used for special purposes.
Improve the coordination mechanism of drug procurement and medical insurance fund management
The plan pointed out that for medical institutions that reduce their medical insurance fund expenditures due to standardized use of selected drugs, the total budget of the medical insurance fund for the current year will not be reduced.
In principle, to carry out by a single disease, according to the diagnosis of diseases related group, according to scores by paying a fixed bed and Japan, do not purchase because with the amount of drug costs decline and reduce its fixed payments standard .
Designated medical institutions that give priority to the use of selected drugs and fulfill their contracts as required shall be encouraged in accordance with the relevant policies for the retention of the balance of the medical insurance fund for centralized procurement of drugs.
Establish a coordination mechanism for procurement prices and medical insurance payment standards, and specific supporting policies will be formulated separately.
Establish a coordination mechanism for procurement prices and medical insurance payment standards, and specific supporting policies will be formulated separately.
Simplify the procurement procedures, give priority to the procurement and use of selected drugs, and ensure the completion of the contract dosage.
Medical institutions that do not purchase and use selected drugs in accordance with regulations will be punished in the total amount of medical insurance indicators, medical insurance designated qualifications, medical institution performance evaluation, and medical institution responsible persons’ target responsibility evaluation.
Medical institutions that do not purchase and use selected drugs in accordance with regulations will be punished in the total amount of medical insurance indicators, medical insurance designated qualifications, medical institution performance evaluation, and medical institution responsible persons’ target responsibility evaluation.
Medical Network News on June 3 At present, provinces have successively released provincial-level centralized procurement plans for 2021.
On June 1, the Anhui Provincial Medical Insurance Bureau issued the "2021 Anhui Province Drug Centralized Procurement Work Plan", which will select large-volume, high-value, and relatively competitive drugs from unreviewed drugs, and carry out provincial-level centralized procurement.
Use bidding, bargaining, etc.
to determine the selected enterprises .
Enterprise business enterpriseUse bidding, bargaining, etc.
to determine the selected enterprises .
Implementation scope: Public medical institutions and military medical institutions in the whole province should participate.
Medical insurance designated social medical institutions shall be implemented in accordance with the requirements of designated agreement management.
Medical insurance designated social medical institutions shall be implemented in accordance with the requirements of designated agreement management.
Procurement cycle: In principle, the procurement cycle of selected drugs is not less than one year.
If the selected varieties are included in the scope of centralized drug procurement organized by the state, or if the procurement cycle needs to be adjusted for other reasons, follow-up related announcements shall prevail.
If the selected varieties are included in the scope of centralized drug procurement organized by the state, or if the procurement cycle needs to be adjusted for other reasons, follow-up related announcements shall prevail.
Drug Scope: Among the generic drugs corresponding to generic drugs that have never passed the consistency evaluation, select some drugs with large clinical usage, high purchase amount, and relatively sufficient competition, and organize the province's large-scale procurement.
Finalist standards: including quality finalist standards and supply finalist standards.
The quality entry standards mainly consider the clinical efficacy of drugs, the safety of use, supervision and sampling, and quality standards.
The supply shortlisted criteria mainly consider the production capacity and supply stability of the enterprise.
The quality entry standards mainly consider the clinical efficacy of drugs, the safety of use, supervision and sampling, and quality standards.
The supply shortlisted criteria mainly consider the production capacity and supply stability of the enterprise.
Procurement form: Determine the review group according to the attributes, quality and market structure of the purchased drugs, comprehensively consider the quality, efficacy, adverse reactions and prices of the drugs and other factors, and determine the selected companies in the form of bidding and bargaining according to the competitive situation.
Adverse reactions adverse reactions adverse reactions With the amount of purchases to the amount of the price change.
Calculate the agreed total purchase amount of the selected drugs based on not less than 50% of the total consumption of relevant drugs in the alliance medical institutions last year, carry out the purchase with a quantity, and implement the agreed purchase volume of the selected drugs to each medical institution in the alliance.
Procurement Procurement ProcurementCalculate the agreed total purchase amount of the selected drugs based on not less than 50% of the total consumption of relevant drugs in the alliance medical institutions last year, carry out the purchase with a quantity, and implement the agreed purchase volume of the selected drugs to each medical institution in the alliance.
Combination of recruitment and acquisition, guaranteed use.
For the selected varieties, the alliance medical institutions shall give priority to use, to ensure that the agreed procurement volume is completed within the procurement cycle.
For the remaining amount, medical institutions can purchase other online varieties at a reasonable price through the provincial platform under the premise of giving priority to purchasing and ensuring the completion of the selected drugs.
Public medical institutions implement "zero markup sales" according to the selected price, and second bargaining is strictly prohibited.
For the selected varieties, the alliance medical institutions shall give priority to use, to ensure that the agreed procurement volume is completed within the procurement cycle.
For the remaining amount, medical institutions can purchase other online varieties at a reasonable price through the provincial platform under the premise of giving priority to purchasing and ensuring the completion of the selected drugs.
Public medical institutions implement "zero markup sales" according to the selected price, and second bargaining is strictly prohibited.
The fund is paid in advance and the funds are paid back in time.
On the basis of the total budget of the medical insurance fund, the medical insurance agencies in the overall planning area shall prepay to medical institutions no less than 30% of the agreed annual purchase amount as a working capital for the medical institutions to pay the enterprise for drug purchases, and the special funds are used for special purposes.
Medicine, medicine, medicineOn the basis of the total budget of the medical insurance fund, the medical insurance agencies in the overall planning area shall prepay to medical institutions no less than 30% of the agreed annual purchase amount as a working capital for the medical institutions to pay the enterprise for drug purchases, and the special funds are used for special purposes.
Improve the coordination mechanism of drug procurement and medical insurance fund management
Improve the coordination mechanism of drug procurement and medical insurance fund management The plan pointed out that for medical institutions that reduce their medical insurance fund expenditures due to standardized use of selected drugs, the total budget of the medical insurance fund for the current year will not be reduced.
In principle, to carry out by a single disease, according to the diagnosis of diseases related group, according to scores by paying a fixed bed and Japan, do not purchase because with the amount of drug costs decline and reduce its fixed payments standard .
Standard Standard Standard Designated medical institutions that give priority to the use of selected drugs and fulfill their contracts as required shall be encouraged in accordance with the relevant policies for the retention of the balance of the medical insurance fund for centralized procurement of drugs.
Establish a coordination mechanism for procurement prices and medical insurance payment standards, and specific supporting policies will be formulated separately.
Establish a coordination mechanism for procurement prices and medical insurance payment standards, and specific supporting policies will be formulated separately.
Simplify the procurement procedures, give priority to the procurement and use of selected drugs, and ensure the completion of the contract dosage.
Medical institutions that do not purchase and use selected drugs in accordance with regulations will be punished in the total amount of medical insurance indicators, medical insurance designated qualifications, medical institution performance evaluation, and medical institution responsible persons’ target responsibility evaluation.
Medical institutions that do not purchase and use selected drugs in accordance with regulations will be punished in the total amount of medical insurance indicators, medical insurance designated qualifications, medical institution performance evaluation, and medical institution responsible persons’ target responsibility evaluation.
